Ceramide Signaling and Metabolism in Pathophysiological States of the Lung

Irina Petrache, Evgeny V. Berdyshev

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Following the discovery of ceramide as the central signaling and metabolic relay among sphingolipids, studies of its involvement in lung health and pathophysiology have exponentially increased. In this review, we highlight key studies in the context of recent progress in metabolomics and translational research methodologies. Evidence points toward an important role for the ceramidesphingosine-1-phosphate rheostat in maintaining lung cell survival, vascular barrier function, and proper host response to airway microbial infections. Sphingosine kinase 1 has emerged as an important determinant of sphingosine-1-phosphate lung levels, which, when aberrantly high, contribute to lung fibrosis, maladaptive vascular remodeling, and allergic asthma. New sphingolipid metabolites have been discovered as potential biomarkers of several lung diseases. Although multiple acute and chronic lung pathological conditions involve perturbations in sphingolipid signaling and metabolism, there are specific patterns, unique sphingolipid species, enzymes, metabolites, and receptors, which have emerged that deepen our understanding of lung pathophysiology and inform the development of new therapies for lung diseases.

Original languageEnglish (US)
Pages (from-to)463-480
Number of pages18
JournalAnnual Review of Physiology
Volume78
DOIs
StatePublished - Feb 10 2016
Externally publishedYes

Fingerprint

Ceramides
Sphingolipids
Lung
Lung Diseases
Translational Medical Research
Metabolomics
Blood Vessels
Cell Survival
Fibrosis
Research Design
Asthma
Biomarkers
Phosphates
Health
Enzymes
Infection

Keywords

  • Airways
  • Apoptosis
  • Inflammation
  • Metabolomics
  • Pulmonary
  • Sphingolipids

ASJC Scopus subject areas

  • Physiology

Cite this

Ceramide Signaling and Metabolism in Pathophysiological States of the Lung. / Petrache, Irina; Berdyshev, Evgeny V.

In: Annual Review of Physiology, Vol. 78, 10.02.2016, p. 463-480.

Research output: Contribution to journalArticle

@article{eec9fe72a50d4ec99f19b88c26658379,
title = "Ceramide Signaling and Metabolism in Pathophysiological States of the Lung",
abstract = "Following the discovery of ceramide as the central signaling and metabolic relay among sphingolipids, studies of its involvement in lung health and pathophysiology have exponentially increased. In this review, we highlight key studies in the context of recent progress in metabolomics and translational research methodologies. Evidence points toward an important role for the ceramidesphingosine-1-phosphate rheostat in maintaining lung cell survival, vascular barrier function, and proper host response to airway microbial infections. Sphingosine kinase 1 has emerged as an important determinant of sphingosine-1-phosphate lung levels, which, when aberrantly high, contribute to lung fibrosis, maladaptive vascular remodeling, and allergic asthma. New sphingolipid metabolites have been discovered as potential biomarkers of several lung diseases. Although multiple acute and chronic lung pathological conditions involve perturbations in sphingolipid signaling and metabolism, there are specific patterns, unique sphingolipid species, enzymes, metabolites, and receptors, which have emerged that deepen our understanding of lung pathophysiology and inform the development of new therapies for lung diseases.",
keywords = "Airways, Apoptosis, Inflammation, Metabolomics, Pulmonary, Sphingolipids",
author = "Irina Petrache and Berdyshev, {Evgeny V.}",
year = "2016",
month = "2",
day = "10",
doi = "10.1146/annurev-physiol-021115-105221",
language = "English (US)",
volume = "78",
pages = "463--480",
journal = "Annual Review of Physiology",
issn = "0066-4278",
publisher = "Annual Reviews Inc.",

}

TY - JOUR

T1 - Ceramide Signaling and Metabolism in Pathophysiological States of the Lung

AU - Petrache, Irina

AU - Berdyshev, Evgeny V.

PY - 2016/2/10

Y1 - 2016/2/10

N2 - Following the discovery of ceramide as the central signaling and metabolic relay among sphingolipids, studies of its involvement in lung health and pathophysiology have exponentially increased. In this review, we highlight key studies in the context of recent progress in metabolomics and translational research methodologies. Evidence points toward an important role for the ceramidesphingosine-1-phosphate rheostat in maintaining lung cell survival, vascular barrier function, and proper host response to airway microbial infections. Sphingosine kinase 1 has emerged as an important determinant of sphingosine-1-phosphate lung levels, which, when aberrantly high, contribute to lung fibrosis, maladaptive vascular remodeling, and allergic asthma. New sphingolipid metabolites have been discovered as potential biomarkers of several lung diseases. Although multiple acute and chronic lung pathological conditions involve perturbations in sphingolipid signaling and metabolism, there are specific patterns, unique sphingolipid species, enzymes, metabolites, and receptors, which have emerged that deepen our understanding of lung pathophysiology and inform the development of new therapies for lung diseases.

AB - Following the discovery of ceramide as the central signaling and metabolic relay among sphingolipids, studies of its involvement in lung health and pathophysiology have exponentially increased. In this review, we highlight key studies in the context of recent progress in metabolomics and translational research methodologies. Evidence points toward an important role for the ceramidesphingosine-1-phosphate rheostat in maintaining lung cell survival, vascular barrier function, and proper host response to airway microbial infections. Sphingosine kinase 1 has emerged as an important determinant of sphingosine-1-phosphate lung levels, which, when aberrantly high, contribute to lung fibrosis, maladaptive vascular remodeling, and allergic asthma. New sphingolipid metabolites have been discovered as potential biomarkers of several lung diseases. Although multiple acute and chronic lung pathological conditions involve perturbations in sphingolipid signaling and metabolism, there are specific patterns, unique sphingolipid species, enzymes, metabolites, and receptors, which have emerged that deepen our understanding of lung pathophysiology and inform the development of new therapies for lung diseases.

KW - Airways

KW - Apoptosis

KW - Inflammation

KW - Metabolomics

KW - Pulmonary

KW - Sphingolipids

UR - http://www.scopus.com/inward/record.url?scp=84958613659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958613659&partnerID=8YFLogxK

U2 - 10.1146/annurev-physiol-021115-105221

DO - 10.1146/annurev-physiol-021115-105221

M3 - Article

VL - 78

SP - 463

EP - 480

JO - Annual Review of Physiology

JF - Annual Review of Physiology

SN - 0066-4278

ER -